UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
| ||
| (Address of principal executive offices) (Zip Code) | ||
| ( | ||
| (Registrant’s Telephone Number, Including Area Code) | ||
| Not Applicable | ||
| (Former Name or Former Address, if Changed Since Last Report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01. | Other Events. |
On June 15, 2022, AMN Healthcare Services, Inc. (the "Company") issued a press release announcing an increase to its share repurchase program. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press Release issued by the Company on June 15, 2022 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AMN Healthcare Services, Inc. | |||
Date: June 15, 2022 |
By: | /s/ Susan R. Salka | |
| Susan R. Salka | |||
| President & Chief Executive Officer | |||
EXHIBIT 99.1
AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program
DALLAS, June 15, 2022 - The Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (NYSE: AMN, the “Company”) authorized an additional $250 million under the Company’s repurchase program for the company’s common stock (the “Increased Company Repurchase Program”).
The Company has repurchased 6.76 million shares of common stock at an average price of $77.44 per share excluding broker’s fees, resulting in an aggregate purchase price of $523.5 million, under the Share Repurchase Program since first authorized in 2016. Since the beginning of the second quarter, the Company has repurchased 1.88 million shares at an average price of $92.65 for $173.8 million. The total remaining dollar value of common stock that may be repurchased under the Increased Company Repurchase Program is approximately $326.3 million.
The Increased Company Repurchase Program does not require the purchase of any minimum number of shares, does not have an expiration date, and may be suspended or discontinued at any time. The amount and timing of the purchases will depend on a number of factors including the price of the Company’s shares, trading volume, Company performance, Company liquidity, general economic and market conditions and other factors that the Company’s management believes are relevant.
Repurchases may be made from cash on hand, free cash flow generated from the Company’s business or from the Company’s credit facilities. Repurchases may also be made pursuant to one or more plans established pursuant to Rule 10b5-1 under the Exchange Act, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading restrictions.
About
AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations
across the nation. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative
recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their
workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed
services programs, clinical and interim healthcare leaders, temporary staffing, executive search solutions, vendor management systems,
recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, credentialing and
other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent
care centers, home health facilities, schools and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining
a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and
perspectives enables our innovation and leadership in the healthcare services industry. For more information about AMN Healthcare, visit www.amnhealthcare.com
Investor Contact
Randle Reece
Director, Investor Relations
AMN Healthcare
(866) 861-3229
investorrelations@amnhealthcare.com